Get started
ALLIGATOR BIOSCIENCE ABALLIGATOR BIOSCIENCE ABALLIGATOR BIOSCIENCE AB

ALLIGATOR BIOSCIENCE AB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ATORX chart


Full chart

ATORX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪188.75 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.2270 SEK
Net income (FY)
‪−248.59 M‬ SEK
Revenue (FY)
‪58.11 M‬ SEK
Shares float
‪402.08 M‬
Beta (1Y)
−0.86

Employees


Employees (FY)
58
Change (1Y)
+5 +9.43%
Revenue / Employee (1Y)
‪1.00 M‬ SEK
Net income / Employee (1Y)
‪−4.29 M‬ SEK

About ALLIGATOR BIOSCIENCE AB


Sector
Health Technology
Industry
Biotechnology
CEO
Søren Bregenholt
Website
alligatorbioscience.com
Headquarters
Lund
Founded
2000
ISIN
SE0000767188
FIGI
BBG00F5R5G37
Alligator Bioscience AB is a biotechnology company, which engages in the development of novel immuno-oncology drugs. The firm specializes in the development of tumor-directed immunotherapies. Its pipeline includes Mitazalimab, ATOR-1017, ALG.APV-527, Neo-X-Prime, and other research projects. The company was founded by Carl Arne Krister Borrebaeck in 2001 and is headquartered in Lund, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ATORX news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ATORX is 0.2490 SEK — it has decreased by −1.97% in the past 24 hours. Watch ALLIGATOR BIOSCIENCE AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ALLIGATOR BIOSCIENCE AB stocks are traded under the ticker ATORX.
ATORX stock has fallen by −7.78% compared to the previous week, the month change is a −54.31% fall, over the last year ALLIGATOR BIOSCIENCE AB has showed a −62.84% decrease.
We've gathered analysts' opinions on ALLIGATOR BIOSCIENCE AB future price: according to them, ATORX price has a max estimate of 1.50 SEK and a min estimate of 1.50 SEK. Watch ATORX chart and read a more detailed ALLIGATOR BIOSCIENCE AB stock forecast: see what analysts think of ALLIGATOR BIOSCIENCE AB and suggest that you do with its stocks.
ATORX reached its all-time high on Nov 23, 2016 with the price of 35.2350 SEK, and its all-time low was 0.2155 SEK and was reached on Dec 4, 2024. View more price dynamics on ATORX chart.
See other stocks reaching their highest and lowest prices.
ATORX stock is 9.45% volatile and has beta coefficient of −0.86. Track ALLIGATOR BIOSCIENCE AB stock price on the chart and check out the list of the most volatile stocks — is ALLIGATOR BIOSCIENCE AB there?
Today ALLIGATOR BIOSCIENCE AB has the market capitalization of ‪188.75 M‬, it has decreased by −4.87% over the last week.
Yes, you can track ALLIGATOR BIOSCIENCE AB financials in yearly and quarterly reports right on TradingView.
ALLIGATOR BIOSCIENCE AB is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
ATORX net income for the last quarter is ‪−66.51 M‬ SEK, while the quarter before that showed ‪−49.21 M‬ SEK of net income which accounts for −35.15% change. Track more ALLIGATOR BIOSCIENCE AB financial stats to get the full picture.
No, ATORX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 58.00 employees. See our rating of the largest employees — is ALLIGATOR BIOSCIENCE AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLIGATOR BIOSCIENCE AB EBITDA is ‪−232.69 M‬ SEK, and current EBITDA margin is −416.97%. See more stats in ALLIGATOR BIOSCIENCE AB financial statements.
Like other stocks, ATORX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIGATOR BIOSCIENCE AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALLIGATOR BIOSCIENCE AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALLIGATOR BIOSCIENCE AB stock shows the sell signal. See more of ALLIGATOR BIOSCIENCE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.